JA_Redacted_final.pdf

CUI//SP-PROCURE

Control Number: 22-RHCO-P-246

CUI//SP PROCURE

1 SEP 2021

Justification Review Document For Sole Source - FAR Part 13.501*

(*Format follows FAR 6.303-2, but modified to reflect FAR subpart 13.5 procedures)

Program/Equipment: Radiometer Arterial Blood Gas Analyzer Reagents for the Department of Pathology, Brian D. Allgood Army Community Hospital (BDAACH), Korea.

Authority: 41 United States Code 1901 as implemented in Federal Acquisition Regulation 13.501(a)(1)(ii), sole source (including brand name) under the authority of the simplified procedures for certain commercial items.

Amount: (12-month base period with four 12-month option periods.

Prepared by:

Typed Name: DSN:

Title:

E-mail:

Contracting Officer:

Typed Name:

Date Reviewed: __________________ E-Mail:

Technical Representative:

Typed Name:

Title:

E-mail:

Controlled by: USAHCA Controlled by: RHCO-P CUI Category:

PROCURE LDC: FEDCON ONLY

POC:

SM

Radiometer Arterial Blood Gas Analyzer Reagents for the Dept. of Pathology, BDAACH, Korea

CUI//SP PROCURE

2 SEP 2021

Requirements Representative:

Typed Name:

Title:

E-mail:

Sole Source Justification and Approval

Radiometer Arterial Blood Gas Analyzer Reagents for the Dept. of Pathology, BDAACH, Korea

CUI//SP PROCURE

3 SEP 2021

Sole Source Justification and Approval Under FAR 13.501

1. Contracting Activity: US Army Medical Command Army Health Contracting Activity Regional Health Contracting Office – Pacific Bldg 339, Clark Road Fort Shafter, HI 96858-5098

2. Description of Action: Request approval for a new Indefinite Delivery Indefinite Quantity (IDIQ) contract with Firm Fixed Prices for the Department of Pathology, Brian D. Allgood Army Community Hospital (BDAACH), Korea. Defense Healthcare Program (DHP) funds will be used. FY23 funds are reserved for the minimum guarantee delivery order for the base year.

3. Description of Supplies/Services: The items being purchased are Radiometer Arterial Blood Gas Analyzer (ABGA) reagents. The total estimated value is The period of performance will be for a 12-month base period plus four (4) one-year option periods as follows:

The total estimated value is This requirement will be for a 12-month base period and four (4) option periods as follows:

Base Period: 01 October 2022 to 30 September 2023 Value:

Option Period 1: 01 October 2023 to 30 September 2024 Value:

Option Period 2: 01 October 2024 to 30 September 2025 Value:

Option Period 3: 01 October 2025 to 30 September 2026 Value:

Option Period 4: 01 October 2026 to 30 September 2027 Value:

Total Estimated Value:

4. Authority Cited: 41 United States Code 1901 as implemented in Federal Acquisition Regulation 13.501(a)(1)(ii), sole source (including brand name) under the authority of the simplified procedures for certain commercial items.

5. Reason for Authority Cited: Radiometer Arterial Blood Gas Analyzer (ABGA) reagents are required for use with the government-owned Radiometer Arterial Blood Gas analyzers. These reagents measure the amount of arterial gases such as Oxygen (O2), pH, PO2 and Carbon Dioxide (CO2). To ensure our healthcare professionals can continue to efficiently screen, diagnose, and provide patient specific treatment, particularly for acute conditions, it is essential that the required supplies are available for use with the government-owned Radiometer ABGA. The only reagents that are compatible with these Radiometer analyzers are the Radiometer branded reagents.

Radiometer Arterial Blood Gas Analyzer Reagents for the Dept. of Pathology, BDAACH, Korea

CUI//SP PROCURE

4 SEP 2021

Failure to obtain the required supplies will render the analyzers unusable, which would significantly jeopardize patient health, care, and safety.

6. Efforts to Obtain Competition:

a. Effective Competition: The notices required by FAR 5.201 shall be published on the SAM.gov website and any quotation received shall be considered. A sources sought notice was posted on SAM.gov on 18 May 2022, inviting all responsible sources to submit a capability statement before the closing date of 25 May 2022.

b. Subcontracting Competition: This requirement does not meet the threshold for requiring a subcontracting plan as required by FAR 19.702(a).

7. Actions to Increase Competition: Ongoing market research will be performed to determine if alternative sources of this service become available.

8. Market Research: The contracting officer performed market research within the past 12 months, which has shown that the Radiometer ABGA reagents are commercial in nature and are utilized by private, public, and government medical facilities. The Requiring Activity also conducted internet searches and contacted knowledgeable people in the industry within Korea regarding this requirement. As a result, three potential sources who can meet the government’s requirement were identified:

Additionally, Radiometer confirmed that only ABGA reagents can be used on the Radiometer ABGA, and that all their products are proprietary to only Radiometer and its authorized distributors.

9. Interested Sources: To date, no other sources have written to express an interest.

10. Other Facts:

a.

(1) .

(2)

(3)

Radiometer Arterial Blood Gas Analyzer Reagents for the Dept. of Pathology, BDAACH, Korea

CUI//SP PROCURE

5 SEP 2021

(4)

(5)

(7) b.

Radiometer Arterial Blood Gas Analyzer Reagents for the Dept. of Pathology, BDAACH, Korea

CUI//SP PROCURE

6 SEP 2021

11. Technical Certification:

I certify that the supporting data under my cognizance, which are included in the justification are accurate and complete to the best of my knowledge and belief.

Signature: __ _ _Date: _ ____________

Typed Name: Title:

12. Requirements Certification:

I certify that the supporting data under my cognizance, which are included in the justification are accurate and complete to the best of my knowledge and belief.

Signature: ___ __ Date: __ ___________

Typed Name: Title:

13. Fair and Reasonable Cost Determination:

I hereby determine that the anticipated cost to the Government for this contract action will be fair and reasonable. The basis for this determination will be price analysis in accordance with FAR 15.404-1(b). Certified cost or pricing data is not required per FAR 15.403-1(b)(3) because the item and/or service being acquired are considered commercial.

Signature: _ _ ____Date: ________________________

Typed Name: Title:

14. Contracting Officer Certification:

I certify that this justification is accurate and complete to the best of my knowledge and belief. Since this effort exceeds the simplified acquisition threshold but does not exceed

, this certification serves as approval.

Signature: _ _______Date: ________________________

Typed Name: Title:

D